Fibroblast growth factor-21 (FGF-21) synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes

被引：0
|
作者：
Brenner, M. B. [1 ]
Lee, D. V. [1 ]
Bernardo, B. [1 ]
Talukdar, S. [1 ]
机构：
[1] Pfizer, CVMED, Cambridge, MA USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
541
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [1] Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes
    Lee, Darwin V.
    Li, Dongmei
    Yan, Qingyun
    Zhu, Yimin
    Goodwin, Bryan
    Calle, Roberto
    Brenner, Martin B.
    Talukdar, Saswata
    [J]. PLOS ONE, 2014, 9 (11):
  • [2] Fibroblast Growth Factor-21 (FGF-21): A Mediator of Inflammatory Responses to Diets?
    Dixon, Taylor M.
    Sharma, Shaligram
    Forney, Laura A.
    Gettys, Thomas W.
    Wanders, Desiree
    [J]. DIABETES, 2017, 66 : A679 - A679
  • [3] The Association of Impaired Fasting Glucose and Serum Fibroblast Growth Factor-21 (FGF-21)
    Kim, Hanbyul
    Cho, Hochan
    [J]. DIABETES, 2018, 67
  • [4] Fibroblast growth factor-21 (FGF-21), a novel peptide, is associated with whole body and hepatic insulin resistance
    Chavez, Alberto O.
    Molina-Carrion, Marjorie
    Abdul-Ghani, Muhammad
    Folli, Franco
    De-Fronzo, Ralph A.
    Tripathy, Devjit
    [J]. DIABETES, 2008, 57 : A33 - A34
  • [5] PLASMA FIBROBLAST GROWTH FACTOR-21 (FGF-21) LEVELS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
    Miyazaki, Yoshichika
    Saita, Emi
    Miura, Kotaro
    Seki, Toshiki
    Suzuki-Sugihara, Norie
    Ikegami, Yukinori
    Ohmori, Reiko
    Kishimoto, Yoshimi
    Kondo, Kazuo
    Momiyama, Yukihiko
    [J]. ATHEROSCLEROSIS, 2017, 263 : E195 - E196
  • [6] Fibroblast Growth Factor-21 (FGF-21) predicts development of diabetes and pioglitazone attenuates the increase in FGF-21 in subjects with IGT: results from the ACTNOW study
    Tripathy, D.
    Alonzo, R. P.
    Chavez-Velazquez, A.
    Martinez, R.
    Musi, N.
    Defronzo, R.
    [J]. DIABETOLOGIA, 2016, 59 : S164 - S164
  • [7] Fibroblast Growth Factor-21 (FGF-21) as a Novel Marker of Metabolic Complications in Type 2 Diabetes and Obesity
    Matuszek, Beata
    Lenart-Lipinska, Monika
    Duma, Dariusz
    Solski, Janusz
    Nowakowski, Andrzej
    [J]. DIABETES, 2010, 59 : A562 - A562
  • [8] Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus
    Zhang, Mei
    Liu, Ying
    Xiong, Zhong-yun
    Deng, Zhi-yong
    Song, Hao-lan
    An, Zhen-Mei
    [J]. ENDOKRYNOLOGIA POLSKA, 2013, 64 (03) : 220 - 224
  • [9] Overexpression of fibroblast growth factor-21 (FGF-21) protects mesenchymal stem cells against caspase-dependent apoptosis induced by oxidative stress and inflammation
    Linares, Gabriel R.
    Leng, Yan
    Maric, Dragan
    Chuang, De-Maw
    [J]. CELL BIOLOGY INTERNATIONAL, 2020, 44 (10) : 2163 - 2169
  • [10] Increase in Serum Fibroblast Growth Factor-21 (FGF-21) Predicts Development of Diabetes in IGT Subjects and Pioglitazone Attenuates the Increase in FGF-21 and Reduces Conversion of IGT to T2DM
    Alonzo, Ryan
    Chavez-Velazquez, Alberto
    Martinez, Robert
    Velez-Garza, Jorge
    Carreon, Marco
    Musi, Nicolas
    Defronzo, Ralph A.
    Tripathy, Devjit
    [J]. DIABETES, 2016, 65 : A482 - A482
12345